Moody’s Ratings is not shifting from its negative outlook on the health insurance sector, noting continued earnings weakness from high medical cost inflation and limited prospects for profitable growth in 2026.
Officials at the credit ratings company said health insurers are facing low margins across most market segments, and companies likely will focus on redesigning medical plans, reducing benefits, and exiting less profitable markets and geographies this year. The sector’s high exposure to regulations and increased leverage further constrain the industry’s ability to return to sustained profitability over the near term, they added.
See also: Health insurance outlook ‘deteriorating’
Challenges for health insurers in the coming months
Here’s a breakdown of three key challenges the sector faces this year:
The medical loss cost trend remains high and cannot be fully offset by premium increases.
Health insurers continue to face persistently high medical loss cost inflation that has affected virtually all health insurance segments — including Medicare Advantage, Medicaid, the Affordable Care Act individual marketplace, and group commercial. Because policy pricing adjustments and reimbursement rates for services provided have significantly lagged behind medical inflation trends, medical loss ratios have deteriorated significantly and EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) margins have declined to low to mid-single digit levels in 2025, with low prospects for a strong earnings rebound in 2026.
High exposure to government oversight and reimbursement levels challenges health insurers’ business model.
With a significant proportion of health insurers’ revenue tied to government-sponsored programs such as Medicare, Medicaid, and Marketplace, the industry is highly reliant on federal and state government-mandated rules and regulations, changing eligibility requirements, and annual reimbursement levels. This has presented significant challenges to the industry under the current environment of increased government scrutiny and sustained efforts to constrain healthcare spending growth.
Lower earnings prospects constrain growth.
In a change from 2023-24, when Medicaid redetermination drove membership declines in that segment, health insurers experienced membership declines across all market segments in 2025 — reflecting significant re-underwriting actions taken across segments to improve profitability. As insurers remain focused on shoring up earnings, Moody’s expects to see low appetite for growth among the health insurers it rates, as well as continued targeted membership reductions in 2026.
“A key driver of Moody’s negative outlook is the persistently elevated medical cost trend, which has impacted virtually all health insurance segments, including Medicare Advantage, Medicaid, the Affordable Care Act individual marketplace and the commercial market,” according to a Moody’s statement. “Although recent data from [PricewaterhouseCoopers] on commercial health insurance programs and the ACA market indicates that annual medical cost trends may be stabilizing in the high single-digit range, these levels remain substantially above historical levels and have continued to outpace health insurers’ ability to fully offset cost pressures through repricing and benefit design changes.”
Credit: Source link
